FTSE MIB
33.922,16 +40,66 (+0,12%) Dow Jones
37.986,40 +211,02 (+0,56%) Nasdaq
15.282,01 -319,49 (-2,05%) Nikkei 225
37.068,35 -1.011,35 (-2,66%) Petrolio
83,24 +0,51 (+0,62%) Bitcoin EUR
60.020,96 +806,54 (+1,36%)
Cytek Biosciences, Inc. (CTKB)
Dopo ore:
| Chiusura precedente | 5,96 |
| Aperto | 5,88 |
| Denaro | 5,89 x 600 |
| Lettera | 5,93 x 600 |
| Min-Max giorno | 5,76 - 5,99 |
| Intervallo di 52 settimane | 3,80 - 12,31 |
| Volume | |
| Media Volume | 706.993 |
| Capitalizzazione | 774,478M |
| Beta (5 anni mensile) | 1,37 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,09 |
| Prossima data utili | 06 mag 2024 - 10 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 10,00 |
GlobeNewswireCytek® Biosciences Achieves ISO 13485 Certification at Headquarters
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United StatesFREMONT, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that it has received EN ISO 13485:2016 Quality Management System (QMS) certification. The certification applies to Cytek’s headquarters and manufacturing operations in Fremont, California for t
- GlobeNewswire
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming 2023 Cantor Fitzgerald Global Healthcare Conference in New York, New York. Cytek management is scheduled to participate in a fireside chat on Wednesday, September 27th at 1:15 p.m. Eastern Time / 10:15 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation
- GlobeNewswire
Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe
Company to Lead Symposiums at ICCS and ESCCAFREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation of high parameter cell analysis by continuing to have an active presence at key industry events worldwide. The company’s Full Spectrum Profiling™ (FSP™) technology that streamlines workflows, accelerates discoveries and maximizes efficiency will be front and cente
